The deal was annouced on May 25th. The remaining 20% is owned by the founder and CEO of the service Dmitry Petrukhin and top management of the company. The transaction amount was not disclosed.
As per first Deputy Chairman of the Management Board Lev Khasis statement – “I hope that this company will become the platform that will allow to provide services of doctor appointment, and other digital services with improved legislation over time” said Mr. Khasis. According to the banker, in the future docdoc.ru may include such services as telemedicine, drug purchase and delivery (providing medical care with the use of remote communication channels; may the government approve a new version of the Bill on tele-health submitted to the State Duma). “Many international companies are developing artificial intelligence. We hope that after the relevant laws are passed, docdoc.ru will be allowed to realize many services of such kind”, — said Lev Khasis. All of these services at Sberbank are called “digital medicine”.
Right now DocDoc.ru is working by analogy with Uber as online platform that helps you search for doctors from different hospitals based on their ranking and user reviews of medical services. According to the company, the Docdoc.ru market share for online appoinments in the clinics is 98%, and the market share for appointments to a particular doctor is 60%. “Docdoc.ru is the aggregator with 30 thousand doctors and 2 thousand clinics. We are present in 11 major cities and more than 30 smaller cities,” — said Dmitry Petrukhin.
Lev Khasis also told about plans for development of the service over the next several years. “The plan for the market share of digital medicine in three or four years is at 50-60%.” According to Sberbank, the market volume of digital medicine will reach 150-180 billion rubles by 2020.
This project is one of the stages of construction of the so-called Sberbank digital ecosystem, which will connect most effectively through the services of entrepreneurs and users of their services in various fields, including medicine and pharmaceuticals. “At the same time Sberbank does not plan to build some kind of a closed system only for their customers, this platform will be open to customers of other credit organizations”, — said the banker.
The key risk is lack of legal framework for the so-called digital medicine, indicates the head of another service in the field “Yandex.Health” Grigory Bakunov.